Triiodide Anion as a Magnesium-ion Transporter for Low Overpotential Battery Cycling in Iodine-Containing Mg(TFSI)2 Electrolyte

Magnesium iodide (MgI2) solid-electrolyte interface (SEI) layers have previously been shown to protect Mg metal anodes from passivation through products formed during Mg(TFSI)2 electrolyte decomposition (TSFI = trifluorosulfonimide). MgI2 formed in situ from small quantities of I2 added to the electrolyte shows a drastic decrease in the overpotential for magnesium deposition and stripping. In this work, a MgI2 SEI layer was created in an ex situ fashion and then the electrochemical characteristics of this MgI2 SEI layer were probed both alone and with small quantities of I2 or Bu4NI3 additives to identify the electroactive species. Chronopotentiometry (CP) and cyclic voltammetry (CV) show that the MgI2 SEI alone is insufficient for low overpotential magnesium cycling. I(3d) XPS data show that I3- is formed within the SEI layer, which can serve as the electroactive species when ligated with Mg2+ for low overpotential (<50 mV at 0.1 mA cm-2 current density) cycling. Moreover, Raman shifts at 110 and 140 cm-1 are consistent with I3- formation, and these signatures are observed before and after CP experiments. The Mg0 deposition curves in the CV with additives are consistent with diffusive species. Finally, electrochemical impedance spectroscopy (EIS) shows that there is a large decrease in the charge-transfer resistance within the SEI when either I2 or Bu4NI3 additives are used, which supports a solvating effect that facilitates magnesium deposition and stripping.

Microwave Synthesis of Spinel MgFe2O4 Nanoparticles and the Effect of Annealing on Photocatalysis

Through microwave heating in ethanol and with subsequent annealing, crystalline MgFe₂O₄ nanoparticles are produced rapidly and in high yields >99%. Under varied annealing temperatures, the degree of Mg and Fe site inversion changes the optical, electronic, and composition of the nanoparticles. A small particle size of ∼10 nm is achievable with the aid of an ammonium salt mineralizer that caps the particles during nucleation and growth. Particles with the lowest inversion parameter and limited sintering upon annealing (at 600 °C) exhibit the greatest production of hydroxyl radicals under visible light illumination. As such, these particles also facilitate the degradation of methylene blue dye faster than those particles annealed at higher temperature and show a rate constant of 0.061 h^-1 for degrading 10 ppm methylene blue with 20 mg of catalyst.

Photocatalytic primary alcohol oxidation on WO3 nanoplatelets

With the aid of direct heating through microwave irradiation in non-aqueous media, nanocrystalline tungsten(vi) oxide is achievable in 30 minutes at 200 °C, faster and at a lower temperature than conventional synthesis methods.

Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney

These studies were undertaken to examine whether an antagonism between vasopressin and prostaglandin occurs in vivo in the mammalian kidney. All experiments were performed in steroid-replaced hypophysectonized dogs undergoing a water diuresis. In the first group of studied the effect of two consecutive intravenous doses (100 mU) of vasopressin was examined. The second dose of vasopressin was preceded by an injection of the carrier solution for solubilizing indomethacin or neclofenamate. No enhancement of the antidiuretic effect of the second dose of vasopressin was observed as urinary osmolality (Uosm) increased from 92 +/- 5 to 252 +/- 18 mosmol/kg H2O (P less than 0.0001) after the first dose and from 109 +/- 8 to 209 +/- 10 mosmol/kg H2O (P less than 0.001) after the second dose of vasopressin. In another group of studies the second dose of vasopressin was preceded by the administration of a potent inhibitor of prostaglandin synthesis, indomethacin (2 mg/kg). The Uosm increased from 93 +/- 9 to 244 +/- 33 mosmol/kg H2O (P less than 0.001) after the first dose of vasopressin, but after the second dose of vasopressin the Uosm increased to a significantly greater degree from 106 +/- 14 to 702 +/- 69 mosmol/kg H2O (P less than 0.001). In a third group of studies the antidiuretic effect of the same 100-mU dose of vasopressin was examined before and after the administration of meclofenamate (2 mg/kg), an inhibitor of prostaglandin synthesis which is chemically dissimilar from indomethacin. Uosm increased from 83+/-7 to 216+/-16 mosmol/kg H2O (P less than 0.001) after the first dose and from 101 +/- 8 to 734 +/- 86 mosomol/kg H2O (P less than 0.001) after the second dose of vasopressin. As in the indomethacin studies this enhancement in the antidiuretic effects of vasopressin after inhibition of prostaglanding synthesis was highly significant (P less than 0.001). These results therefore implicate a physiological role of prostaglandin in modulating the hydroosmotic effect of vasopressin in the mammalian kidney.